Assoc Prof Darren Lim on dual immunotherapy for nasopharyngeal cancer patients
A chemotherapy-free treatment option known as dual immunotherapy may be on the cards for patients with recurrent or spreading nasopharyngeal cancer. Researchers from the National Cancer Centre Singapore found the treatment method to be effective in the second phase of clinical trials. The study also found patients with lower levels of Epstein-Barr virus DNA -- associated with nose and throat cancer -- had better response and progression-free survival. CNA spoke with Associate Professor Darren Lim, lead author of the study and senior consultant at the National Cancer Centre.
Subscribe to our channel here: https://cna.asia/youtubesub
Subscribe to our news service for must-read stories:
Telegram - https://cna.asia/telegram
WhatsApp - https://cna.asia/whatsapp
Follow us:
CNA: https://cna.asia
CNA Lifestyle: http://www.cnalifestyle.com
Facebook: https://www.facebook.com/channelnewsasia
Instagram: https://www.instagram.com/channelnewsasia
Twitter: https://www.twitter.com/channelnewsasia
TikTok: https://www.tiktok.com/@channelnewsasia
-
Category
No comments found